Attributable One-year Healthcare Cost of Incident Type 2 Diabetes: A Population-wide Difference-in-differences Study in Denmark

Overview

Journal Diabet Med

Specialty Endocrinology

Date 2024 Oct 17

PMID 39415474

Authors

Eskild Klausen Fredslund

Annelli Sandbaek

Thim Praetorius

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of this study is to estimate the causally attributable one-year healthcare costs for individuals getting a type 2 diabetes diagnosis compared to a matched sample and show the incurred costs of medication and in primary and secondary healthcare.

Methods: Causal estimation using a difference-in-differences design to estimate the one-year health care costs attributable to type 2 diabetes. Danish registry data consisting of the entire population in years 2016-2019. Newly diagnosed individuals with type 2 diabetes in 2018 were identified using a validated method. Sociodemographic and historical health data were used to identify a matched control group. Individuals were followed for two years before and one year after the date of diagnosis using. Three cost components were analysed: medication and primary and secondary healthcare costs.

Results: A total of 18,133 individuals were diagnosed with type 2 diabetes in 2018 and matched successfully 1:1 to a control group. The total attributable one-year cost of type 2 diabetes was EUR 1316. The main cost component was hospital care (EUR 1004) and primary care (EUR 167). The total attributable cost of incident diabetes in Denmark in 2018 was approx. EUR 24 million.

Conclusions: The majority of the first year health care cost of incident diabetes is incurred at the hospital level followed by primary care and medication. Our yearly cost estimate per newly diagnosed is considerably lower than estimates from the US and Australia.

Citing Articles

Attributable one-year healthcare cost of incident type 2 diabetes: A population-wide difference-in-differences study in Denmark.

Fredslund E, Sandbaek A, Praetorius T Diabet Med. 2024; 42(3):e15455.

PMID: 39415474 PMC: 11823369. DOI: 10.1111/dme.15455.

References

. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513-1530. PMC: 5081106. DOI: 10.1016/S0140-6736(16)00618-8. View

Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Barnighausen T . The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017; 5(6):423-430. DOI: 10.1016/S2213-8587(17)30097-9. View

Zhuo X, Zhang P, Barker L, Albright A, Thompson T, Gregg E . The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014; 37(9):2557-64. DOI: 10.2337/dc13-2484. View

Nicolaisen S, Pedersen L, Witte D, Sorensen H, Thomsen R . HbA1c-defined prediabetes and progression to type 2 diabetes in Denmark: A population-based study based on routine clinical care laboratory data. Diabetes Res Clin Pract. 2023; 203:110829. DOI: 10.1016/j.diabres.2023.110829. View

Jakobsen M, Kolodziejczyk C, Fredslund E, Bo Poulsen P, Dybro L, Johnsen S . Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study. BMC Health Serv Res. 2017; 17(1):398. PMC: 5469002. DOI: 10.1186/s12913-017-2331-z. View

Rosella L, Lebenbaum M, Fitzpatrick T, OReilly D, Wang J, Booth G . Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis. Diabet Med. 2015; 33(3):395-403. PMC: 5014203. DOI: 10.1111/dme.12858. View

Lynge E, Sandegaard J, Rebolj M . The Danish National Patient Register. Scand J Public Health. 2011; 39(7 Suppl):30-3. DOI: 10.1177/1403494811401482. View

Wallach Kildemoes H, Sorensen H, Hallas J . The Danish National Prescription Registry. Scand J Public Health. 2011; 39(7 Suppl):38-41. DOI: 10.1177/1403494810394717. View

Dinh N, de Graaff B, Campbell J, Jose M, Burgess J, Saunder T . Incremental healthcare expenditure attributable to diabetes mellitus: A cost of illness study in Tasmania, Australia. Diabet Med. 2022; 39(6):e14817. DOI: 10.1111/dme.14817. View

10.

M Whaley C, Pera M, Cantor J, Chang J, Velasco J, Hagg H . Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic. JAMA Netw Open. 2020; 3(11):e2024984. PMC: 7645698. DOI: 10.1001/jamanetworkopen.2020.24984. View

11.

Kahm K, Stark R, Laxy M, Schneider U, Leidl R . Assessment of excess medical costs for persons with type 2 diabetes according to age groups: an analysis of German health insurance claims data. Diabet Med. 2019; 37(10):1752-1758. DOI: 10.1111/dme.14213. View

12.

Davis K . The Danish health system through an American lens. Health Policy. 2002; 59(2):119-32. DOI: 10.1016/s0168-8510(01)00202-0. View

13.

Visaria J, Iyer N, Raval A, Kong S, Hobbs T, Bouchard J . Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study. Clinicoecon Outcomes Res. 2020; 12:423-434. PMC: 7428320. DOI: 10.2147/CEOR.S247498. View

14.

Ettaro L, Songer T, Zhang P, Engelgau M . Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics. 2004; 22(3):149-64. DOI: 10.2165/00019053-200422030-00002. View

15.

Palmer A, Holt R . Using health economics to count the cost of diabetes. Diabet Med. 2019; 36(8):925-926. DOI: 10.1111/dme.14057. View

16.

Zhou X, Shrestha S, Shao H, Zhang P . Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017. Diabetes Care. 2020; 43(10):2396-2402. PMC: 7510041. DOI: 10.2337/dc19-2273. View

17.

Quan J, Ng C . Incremental healthcare costs attributable to type 2 diabetes in Hong Kong: A population-based cost of illness study. Diabet Med. 2022; 40(2):e14970. DOI: 10.1111/dme.14970. View

18.

Sortso C, Green A, Jensen P, Emneus M . Societal costs of diabetes mellitus in Denmark. Diabet Med. 2015; 33(7):877-85. PMC: 5061106. DOI: 10.1111/dme.12965. View

19.

Andersen J, Olivarius N, Krasnik A . The Danish National Health Service Register. Scand J Public Health. 2011; 39(7 Suppl):34-7. DOI: 10.1177/1403494810394718. View

20.

Janssen L, Hiligsmann M, Elissen A, Joore M, Schaper N, Bosma J . Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study. Diabet Med. 2020; 37(10):1759-1765. PMC: 7539911. DOI: 10.1111/dme.14285. View